SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-021590
Filing Date
2023-04-28
Accepted
2023-04-28 16:21:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20008281x2_defa14a.htm DEFA14A 9070
2 ny20008281x2_nc1.jpg GRAPHIC 1901807
3 ny20008281x2_nc2.jpg GRAPHIC 1260115
  Complete submission text file 0001140361-23-021590.txt   4065547
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 23866701
SIC: 2834 Pharmaceutical Preparations